Adverse events300

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 300

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Pyrexia	General disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	160	378
other	Pyrexia	General disorders	Nivolumab	22	387
other	Fatigue	General disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	154	378
other	Fatigue	General disorders	Nivolumab	112	387
other	Influenza like illness	General disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	114	378
other	Influenza like illness	General disorders	Nivolumab	11	387
other	Asthenia	General disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	70	378
other	Asthenia	General disorders	Nivolumab	38	387
other	Chills	General disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	55	378
other	Chills	General disorders	Nivolumab	7	387
other	Face oedema	General disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	21	378
other	Face oedema	General disorders	Nivolumab	1	387
other	Oedema peripheral	General disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	21	378
other	Oedema peripheral	General disorders	Nivolumab	7	387
other	Pruritus	Skin and subcutaneous tissue disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	95	378
other	Pruritus	Skin and subcutaneous tissue disorders	Nivolumab	54	387
other	Rash	Skin and subcutaneous tissue disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	75	378
other	Rash	Skin and subcutaneous tissue disorders	Nivolumab	34	387
other	Rash maculo-papular	Skin and subcutaneous tissue disorders	Combination of Bempegaldesleukin (NKTR-214) + Nivolumab	55	378
other	Rash maculo-papular	Skin and subcutaneous tissue disorders	Nivolumab	21	387

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04410445/events

API reference For AI assistants

Adverse events300

Sources 3

Read this list from software.